论文期刊

取消

高级检索

检索历史清除

首页> European radiology> Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.

Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.

导出原文传递

翻译打印收藏纠错

作者： Ning,Lv ^[1] ; Yanan,Kong ^[2] ; Luwen,Mu ^[1] ; Tao,Pan ^[1] ; Qiankun,Xie ^[1] ; Ming,Zhao ^[3]

作者单位： Department of Medical Imaging and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, China. ^[1] Department of Breast Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, China. ^[2] Department of Medical Imaging and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, Guangdong, 510060, China. zhaoming@sysucc.org.cn. ^[3]

关键词 Cyclooxygenase-2 inhibitor Inoperable hepatocellular carcinoma Parecoxib sodium Postoperative pain control Transcatheter arterial chemoembolization

主题词癌, 肝细胞(Carcinoma, Hepatocellular);化学栓塞, 治疗性(Chemoembolization, Therapeutic);环氧化酶2抑制剂(Cyclooxygenase 2 Inhibitors);双盲法(Double-Blind Method);女(雌)性(Female);人类(Humans);异恶唑类(Isoxazoles);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);疼痛, 手术后(Pain, Postoperative);围手术期医护(Perioperative Care);前瞻性研究(Prospective Studies);治疗结果(Treatment Outcome)

DOI 10.1007/s00330-016-4207-8

PMID 26801163

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览38

European radiology

European radiology

2016年26卷10期

3492-9页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷